SCHEDULE: Saba Capital Nominates Trustee for Gabelli Dividend Trust Board

Saba Capital Management, a significant shareholder in The Gabelli Dividend & Income Trust, has nominated Andre Clemot as an independent trustee for the 2026 annual meeting, while also disclosing recent share sales.

Summary

• Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (Reporting Persons) beneficially own 5,694,804 Common Shares, representing 6.43% of The Gabelli Dividend & Income Trust.
• The Reporting Persons paid approximately $130,101,348 to acquire the Common Shares.
• Saba Capital Master Fund, Ltd. (SCMF), advised by Saba Capital, has nominated Andre Clemot as an independent trustee for election to the Board at the Issuer's 2026 annual meeting of shareholders.
• A Nominee Agreement is in place where SCMF will cover proxy solicitation costs and indemnify Mr. Clemot against litigation related to his nomination.
• The filing also details numerous "Sell" transactions of Common Shares by Saba Capital between November 14, 2025, and January 7, 2026, at prices ranging from $26.46 to $28.23.
• One transaction on November 28, 2025, involved a pro-rata distribution in-kind of 370 shares for no consideration.

Sentiment

Score: 6

Explanation: The filing presents a mixed sentiment. The activist nomination by Saba Capital could be seen as a positive catalyst for potential governance improvements and shareholder value creation. However, the simultaneous and extensive selling of shares by Saba Capital over the past two months introduces a negative signal, suggesting a reduction in conviction or a strategic exit, which could temper optimism regarding the activist move.

Positives

• Saba Capital is actively engaging in corporate governance by nominating an independent trustee, potentially aiming to enhance shareholder value.
• The nominee, Andre Clemot, is described as an "independent trustee," suggesting a focus on objective oversight.
• Saba Capital is covering all proxy-related costs and indemnifying the nominee, reducing personal financial risk for the candidate.

Negatives

• Saba Capital has significantly reduced its holdings through numerous "Sell" transactions over the past two months, which could signal a lack of confidence or a strategic shift.
• The "Sell" transactions occurred across a range of prices, indicating a consistent divestment strategy rather than a single opportunistic sale.

Risks

• The proxy solicitation and potential election of a new trustee could lead to a contested board, potentially causing instability or diverting management's focus.
• The indemnification agreement for the nominee does not cover actions taken as a trustee, leaving the nominee exposed to liabilities once elected.
• Saba Capital's ongoing share sales could put downward pressure on the stock price or be perceived negatively by other investors.

Future Outlook

Saba Capital Master Fund, Ltd. intends to nominate Andre Clemot as an independent trustee for election to The Gabelli Dividend & Income Trust's Board at the 2026 annual meeting of shareholders, expected around May 2026. This indicates a future proxy solicitation and potential change in board composition.

Industry Context

This filing exemplifies shareholder activism, a common strategy where large investors seek to influence a company's management or strategic direction, often through board nominations. Saba Capital is known for its activist approach, particularly in the closed-end fund space. The nomination of an independent trustee suggests an attempt to improve governance or unlock shareholder value, a trend seen across various industries where investors push for changes to enhance returns.

Comparison to Industry Standards

• Saba Capital's 6.43% stake is a significant activist position, typically sufficient to exert influence, aligning with common thresholds for activist campaigns (often above 5%).
• The nomination of an independent trustee is a standard tactic in activist campaigns, aiming to bring fresh perspectives and challenge incumbent management or board decisions, similar to actions by other activist funds like Starboard Value or Elliott Management in their respective targets.
• The indemnification agreement for the nominee is a standard practice to protect individuals from legal costs associated with proxy contests, ensuring qualified candidates are willing to participate.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased shareholder value if the activist campaign is successful in driving strategic changes. However, Saba Capital's share sales could create uncertainty.
• Board of Trustees: The nomination introduces a potential challenge to the incumbent board, possibly leading to a contested election and shifts in board dynamics.
• Management: May face increased scrutiny and pressure to address concerns raised by the activist investor.

Next Steps

• Saba Capital Master Fund, Ltd. will proceed with a proxy solicitation in respect of the 2026 annual meeting of shareholders.
• The Issuer's 2026 annual meeting of shareholders is expected to be held around May 2026, where Andre Clemot will stand for election as an independent trustee.
• The nominee, Andre Clemot, will complete questionnaires from the Fund and the Nominating Party and provide consent to being nominated and serving as a trustee.

Key Dates

Recommendation

The filing presents a mixed signal for investors. While the nomination of an independent trustee by an activist investor like Saba Capital could be a catalyst for positive corporate governance changes and potential value creation, the simultaneous and substantial selling of shares by Saba Capital itself over the past two months introduces a significant cautionary note. This divestment suggests a potential lack of long-term conviction or a strategic re-evaluation by the activist, which could offset the positive implications of the board nomination. Therefore, a "hold" recommendation is appropriate as investors should monitor the outcome of the proxy contest and Saba Capital's future actions before making a definitive buy or sell decision.

Keywords

Saba Capital Management, Gabelli Dividend & Income Trust, Schedule 13D/A, Activist Investor, Board Nomination, Proxy Solicitation, Corporate Governance, Shareholder Activism, Trustee Election, Common Shares, Investment Fund, Boaz R. Weinstein, Andre Clemot